naphazoline has been researched along with plx4032 in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Aractingi, S; Avril, MF; Boitier, F; Carlotti, A; Chanal, J; Dupin, N; Herms, F; Kramkimel, N; Regnier-Rosencher, E | 1 |
1 other study(ies) available for naphazoline and plx4032
Article | Year |
---|---|
Age and clear eyes are associated with an increased risk of cutaneous squamous cell carcinomas in vemurafenib-treated melanoma patients.
Topics: Adrenergic alpha-Agonists; Age Factors; Carcinoma, Squamous Cell; Female; Humans; Indoles; Male; Melanoma; Middle Aged; Naphazoline; Retrospective Studies; Risk Factors; Skin Neoplasms; Sulfonamides; Vemurafenib | 2016 |